Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Arthritis Advocacy Spotlights the Military: Veterans, including a rheumatologist, educate lawmakers about arthritis’ impact & the need for research funding

Susan Bernstein  |  February 22, 2019

On Feb. 13, the ACR co-sponsored Arthritis 101, its biennial arthritis advocacy lunch briefing at the U.S. Capitol, highlighting the disproportionate impact of rheumatic disease on active members of the armed forces and veterans. The event, co-sponsored by the Arthritis Foundation (AF), is part of the ACR’s effort to support inclusion of $20 million in dedicated funding for arthritis-focused medical research in the Department of Defense (DoD) Congressionally Directed Medical Research Program (CDMRP) budget.

Panelist Colin Edgerton, MD, FACP, RhMSUS
One of the event’s three panelists, Colin C. Edgerton, MD, FACP, RhMSUS, chair of the ACR Committee on Rheumatologic Care (CORC), says he wanted to help educate lawmakers about the impact of arthritis on service members and veterans, such as the men and women he treated as rheumatology service chief at Eisenhower Army Medical Center from 2006–2013.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“Arthritis is the No. 1 cause of disability among U.S. veterans and the second leading cause1 of medical discharge from the U.S. Army. As such, arthritis erodes the readiness of military units and cuts short promising careers,” says Dr. Edgerton, who is now in private practice in North Charleston, S.C.

“DoD-funded arthritis research has a positive track record in the U.S. military. The Fort Campbell [Ky.] disease-prevention laboratory successfully implemented an injury prevention program in a U.S. Army light infantry division with a high rate of deployments,” he continues. “With dedicated research dollars from the existing DoD CDMRP, longitudinally stable programs, such as these, could focus on supporting war-fighting units in preventing arthritis and improving readiness.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Missed Opportunities

‘I was acutely aware of the missed opportunities. Their arthritis could have been prevented or the damage delayed.’ —Colin C. Edgerton, MD, CORC Chair

According to the U.S. Centers for Disease Control and Prevention (CDC), approximately one in three veterans has arthritis compared with one in four U.S. adults. As an Army rheumatologist, Dr. Edgerton was responsible for evaluating soldiers who were being medically discharged due to their arthritis symptoms, joint damage and disability.

“I was acutely aware of the missed opportunities. Their arthritis could have been prevented or the damage delayed,” says Dr. Edgerton, who also noticed high arthritis prevalence among retired veterans in his care, something he connected to elements of their military service. “While deployed to Iraq with an infantry unit, I recognized the enormous physical strains experienced by our nation’s heroes, and I felt that we owed them our best efforts in preventing and caring for their injuries.”

Page: 1 2 3 | Single Page
Share: 

Filed under:Legislation & Advocacy Tagged with:Arthritis 101Department of Defense (DoD)DoD research funding

Related Articles

    ACR Advocates for Dedicated Department of Defense Arthritis Research Funding

    January 16, 2020

    The ACR and RheumPAC are working to secure an annual allocation of $20 million dedicated to research on arthritis prevention and treatment in the Congressionally Directed Medical Research Program budget.

    ACR Hosts Arthritis 101 Briefing on Capitol Hill

    February 3, 2017

    On Jan. 31, the ACR partnered with the Arthritis Foundation to host an Arthritis 101 Congressional briefing on Capitol Hill. Panelists educated new and returning members of Congress and their staffers about arthritis and other rheumatic diseases, the cost and impact of rheumatic disease to constituents and the U.S. healthcare system, and current policy challenges…

    ACR Partners with Veteran Groups to Call for Dedicated Department of Defense Arthritis Funding

    March 5, 2020

    Twenty-five veteran organizations have signed a letter to Congress supporting the ACR’s request for dedicated DOD arthritis research funds.

    Dusty Trades: Inorganic Dust Exposure During Military Service May Be an Occupational Risk Factor for RA

    October 7, 2021

    Mounting evidence indicates that exposure to inorganic dust is a risk factor for the development of autoimmune diseases. According to a recent study, dust exposure during military service in dusty environments represents an occupational and environmental risk and was associated with a 10% increased risk of developing RA.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences